For its third fiscal quarter (ending September 30), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported a -154% decline in E.P.S. from $1.37 a year ago to $-0.74 in the current quarter. This performance was $-1.36 […]
Warner Bros. Discovery Inc (NASDAQ: WBD) has reported a loss for its third fiscal quarter (ending September 30) of $-0.17 versus a loss $-0.95 for the same period a year ago. This result fell short […]
For its third fiscal quarter (ending September 30), SpartanNash Co (NASDAQ: SPTN) has reported a 22% increase in E.P.S. from $0.27 a year ago to $0.33 in the current quarter. Relative to the consensus estimate […]
On 11/8/23, Superior Group of Cos Inc (NASDAQ: SGC) stock enjoyed a major increase of 10.1%, closing at $9.95. Relative to the market the stock has been weak over the last nine months but has […]
Turtle Beach Corp (NASDAQ: HEAR) stock closed at $9.80 on 11/8/23 after a major increase of 12.6%. The stock has been strong relative to the market over the last nine months and has risen 18.8% […]
For its third fiscal quarter (ending September 30), Ziff Davis Inc (NASDAQ: ZD) has reported a -272% decline in E.P.S. from $0.39 a year ago to $-0.67 in the current quarter. This performance was $-2.20 […]
Urban One Inc (NASDAQ: UONEK) stock closed at $3.45 on 11/8/23 after a major decline of -38.9%. Relative to the market the stock has been strong over the last nine months but has declined -35.0% […]
Take-Two Interactive Software In (NASDAQ: TTWO) has reported E.P.S. of $-3.20 for its second fiscal quarter (ending September 30) versus $-1.54 for the same period a year ago. For the latest four quarters through September […]
Biogen Inc (NASDAQ: BIIB) has reported E.P.S. of $-0.47 for its third fiscal quarter (ending September 30) versus $7.86 for the same period a year ago — a decline of -106%. This performance was $-4.46 […]
Vericel Corp (NASDAQ: VCEL) has reported E.P.S. of $-0.08 for its third fiscal quarter (ending September 30) versus $-0.14 for the same period a year ago. Relative to the consensus estimate of $-0.12, this was […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research